Connect with us

National

They put their lives on the line to save Zimbabwe’s endangered rhinos

Published

on

 BY NOKUTHABA DLAMINI

Columbus Chaitezvi became animated as he narrated a near death experience with a black rhino in Zimbabwe’s Save Valley Conservancy while doing something conservationists believe is the antidote for the high levels of poaching of the endangered species.

Advertisement

Chaitezvi, a senior veterinary officer at the Zimbabwe Parks and Wildlife Management Authority (Zimparks), is part of a team spearheading a project to dehorn the remaining rhinos in the country’s game reserves in order to protect them from poachers.

Conservationists see rhino dehorning as a temporary measure to prevent the killing of the animals for their horns by poachers.

Dehorning is a continuous process as the horn regrows after removal.

Advertisement

Rhinos are targeted by poachers because their horns are in high demand, especially in Asia.

Zimbabwe now has over 1000 rhinos after poachers decimated their population three decades ago and Zimparks believes dehorning is one of the best ways to protect the animals.

Chaitezvi described the dehorning exercise as a dangerous, but worthwhile exercise because of the benefits to the country’s wildlife and tourism industry.

Advertisement

He described the 2019 Save Valley near death experience as part of the hazards of the mission that has seen them dehorning rhinos across the country, which at times comes at the cost of human lives.

“We were at the Save Valley when one of my colleagues who was assisting with the operation said he assumed that the rhino was struggling to breathe and decided to inject it with a reversal drug without notifying us,” Chaitezvi said.

“As I was still doing the work I suddenly saw the rhino opening its eyes and within no time it was up and ready to attack.

Advertisement

“I immediately took off and it was just a second behind me and using my survival skills I decided to take a sharp turn in front of it because rhinos struggle with sharp turns.

“So it passed through and that’s how I was lucky to make it to the next minute.”

His team has several tales to tell about dangers posed by the exercise, but passion and dedication has ensured that they keep their eyes on the ball.

Advertisement

Early this month, a Zimparks ranger who was part of the annual dehorning programme, suffered serious injuries after he was attacked by a black rhino at the Matopos National Park in Matabeleland South.

“We come across these life-threatening encounters on several occasions because we are hardly equipped with necessary resources, but we remain dedicated to fight for these rhinos and save them from extinction,” Chaitezvi said.

“One of my colleagues Ray Makwehe (now deceased) got seriously injured by the same dangerous black rhino type as he was doing the same job and he sustained serious injuries on his thigh and permanently lost one of his fingers too.

Advertisement

“But that did not deter him because he was involved in another helicopter crash that he survived while doing conservation work.

“The tales are many, but we lighten up about them when the work has been fulfilled because ours is to conserve and fight wildlife crimes, and our partners have helped us to slow down poaching of the rhinos over the years inside our national parks which is Lake Kyle Recreational Park, Chivero, Hwange, Matopos and Chipinge.”

He added: “Before the Covid-19 pandemic, we had serious poaching cases happening at one of our private run game Bubye Valley Conservancy and we took action by sending more security and poaching has drastically reduced there.”

Advertisement

Zimparks national rhino coordinator Diana Marewangepo-Chasara said the dehorning exercise targeted mature rhinos to make them unattractive for poachers.

“Dehorning is done to reduce rewards for poachers,” Marewangepo-Chasara said.

“It reduces the amount of horn that the poacher can obtain by killing a rhino and, therefore, the payment that he receives from the sale of the horn.”

Advertisement

Zimparks, however, says it is struggling to implement the dehorning exercise due to financial constraints.

Money is needed to buy drugs to sedate the rhinos before they are dehorned, for transport for the dehorning teams and to buy equipment for rangers.

“The dehorning exercise is extremely costly and as such the biggest challenge to date has been the funding,” Chaitezvi added.

Advertisement

 “Zimparks is facing serious financial challenges, which have resulted mainly from effects of the Covid-19 pandemic as well as the country’s economic challenges and financial constraints also lead to manpower shortages and lack of adequate resources to effectively carry out vital operations.”

Zimparks does not have its own helicopter or fixed wing plane, which means that the Authority has to outsource the services at a high cost.

At times, the dehorning teams have to track the rhinos on foot, which could be dangerous and time consuming, Chaitezvi revealed.

Advertisement

 “We try to use what we have, like in Chivero National Park, we were using Land Cruisers while we also track them on foot which can take the whole day to find one,” he said.

“The drugs are expensive and also the expertise is limited as we are only three instead of four because of economic challenges looking at the effects of Covid-19, but our goal remains the same, (to protect rhinos).”

He said on average, the process of dehorning costs US$2000 per rhino which covers for immobilisation drugs, darting, reversal, oxygen and medication.

Advertisement

“We use etofine opioids drugs, which are costly because they are administered in pairs and this also includes the reversal after the process of dehorning has been done, which costs about US$ 800,” he said.

“On top of that we the dehorning process requires oxygen tanks, dressing kits, antibiotics, pain killers and monitoring gadget for operations and that goes up to US$2000 per rhino and that is why we have had to rely on donor funding to cover one park per year.”

Zimbabwe in May hosted the Africa Elephant Summit in Hwange, which sought to explore ways of promoting sustainable conservation in the region and funding of conservation efforts was topical.

Advertisement

The summit pushed for the liberalisation of trade in wildlife products by developing a viable instrument which will enable African elephant range states to sell ivory stockpiles to raise funds for conservation.

The Hwange Declaration, signed at the end of the summit, made a clarion call for the Convention on International Trade in Endangered Species of Wild Fauna and Flora not to interfere with domestic trade, state sovereignty, and their rights to sustainable use of wildlife.

It will be tabled at the International Wildlife Conference to be held in Panama in November.

Advertisement

If the lobby succeeds, Zimparks can sell its huge stockpiles of ivory to fund conservation efforts such as the dehorning of rhinos, which conservations believe has been instrumental in bringing down cases of poaching across the globe.

According to a new report by International Union for Conservation of Nature (IUCN, globally the overall rhino poaching rates have declined since 2018.

 Trade data suggests the annual estimate of rhino horns entering illegal trade markets have also declined since 2013.

Advertisement

The report says rhino poaching rates in Africa have continued to decline from a peak of 5.3% of the total population in 2015 to 2.3% in 2021.

It added that at least 2,707 rhinos were poached across Africa between 2018 and 2021. – The Standard

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

World AIDS Day: UN Chief says ending AIDS by 2030 “is within grasp”

Published

on

BY SONIA HLOPHE

United Nations Secretary-General António Guterres has marked World AIDS Day with a message urging world leaders to scale up investment, confront stigma and ensure that lifesaving HIV services reach everyone who needs them.

Advertisement

In his statement, Guterres said this year’s commemoration serves as a reminder that the world “has the power to transform lives and futures, and end the AIDS epidemic once and for all.”

He highlighted the major gains achieved over the past decade.

“The progress we have made is undeniable,” he said, noting that “since 2010, new infections have fallen by 40 per cent” while “AIDS-related deaths have declined by more than half.” Access to treatment, he added, “is better than ever before.”

Advertisement

But despite this global progress, the Secretary-General warned that the crisis is far from over.

“For many people around the world, the crisis continues,” he said. “Millions still lack access to HIV prevention and treatment services because of who they are, where they live or the stigma they endure.”

Guterres also raised concern over shrinking resources:

Advertisement

“Reduced resources and services are putting lives at risk and threatening hard-won gains.”

He said ending AIDS requires fully supporting communities, scaling up prevention and ensuring treatment for everyone.

“Ending AIDS means empowering communities, investing in prevention and expanding access to treatment for all people.”

Advertisement

He also called for innovation to be matched by real-world delivery:

“It means uniting innovation with action, and ensuring new tools like injectables reach more people in need.”

Above all, he stressed the need for a human-rights centred response so no one is excluded.

Advertisement

“At every step, it means grounding our work in human rights to ensure no one is left behind.”

With the 2030 global deadline approaching, the UN chief said success is still possible if momentum is sustained.

“Ending AIDS as a public health threat by 2030 is within grasp. Let’s get the job done.”

Advertisement

 

Advertisement
Continue Reading

National

Zimbabwe fast-tracks approval of long-acting HIV prevention drug Lenacapavir

Published

on

BY WANDILE TSHUMA

Zimbabwe has taken a major step in the fight against HIV following the rapid approval of Lenacapavir, a groundbreaking long-acting injectable for HIV pre-exposure prophylaxis (PrEP). The Medicines Control Authority of Zimbabwe (MCAZ) authorised the drug in just 23 days, marking one of the fastest regulatory approvals in the country’s history.

Advertisement

The application, submitted by pharmaceutical company Gilead Sciences in October, underwent an expedited review because of its public health importance. MCAZ says the fast-tracked process did not compromise scientific scrutiny, with the product subjected to a rigorous assessment of its safety, efficacy and quality.

Lenacapavir is designed for adults and adolescents weighing at least 35kg who are HIV-negative but at substantial risk of infection. Unlike traditional daily oral PrEP, the medicine is administered as a six-monthly injection, following an initiation phase that includes one injection and oral tablets on Days 1 and 2. Health authorities say this long-acting formulation could dramatically improve adherence and expand prevention options, particularly for communities where daily pill-taking is difficult.

MCAZ Director-General  Richard T. Rukwata described the approval as a landmark moment in Zimbabwe’s HIV response.

Advertisement

“The rapid approval of Lenacapavir reflects MCAZ’s dedication to accelerating access to trusted, high-quality health products. This milestone brings new hope for HIV prevention and reinforces our commitment to safeguarding public health,” he said.

To fast-track the process, the Authority applied a regulatory reliance approach, drawing on scientific assessments from the World Health Organization’s Prequalification Programme (WHO PQ). This allowed evaluators to build on internationally recognised review processes while ensuring Zimbabwe’s own standards were met.

The introduction of Lenacapavir comes as Zimbabwe continues efforts to reduce new HIV infections, particularly among young people and key populations who face barriers to consistent PrEP use. Public health experts say the drug’s twice-yearly dosing could be a game changer in improving uptake and protection.

Advertisement

MCAZ says it remains committed to ensuring Zimbabweans have access to safe, effective and good-quality medical products, in line with its mandate under the Medicines and Allied Substances Control Act.

Advertisement
Continue Reading

National

Zimbabwe makes gains against TB

Published

on

BY WANDILE TSHUMA

The World Health Organization (WHO) data show that Zimbabwe continues to make measurable gains in its fight against tuberculosis (TB).

Advertisement

According to the Global Tuberculosis Report 2025, Zimbabwe’s estimated TB incidence has declined to 203 per 100,000 population, representing a 3.8 % reduction from 2023. The report states that “TB incidence in Zimbabwe has fallen to 203 per 100 000, a 3.8 % reduction from 2023.” 

On treatment outcomes, the country’s overall success rate for all forms of TB has improved to 91 %, up from 89 % in 2023. The report quotes: “Treatment success for all forms of TB has improved to 91 %, up from 89 % in 2023.” 

For drug-resistant TB (DR-TB), progress has also been recorded: treatment success rose from 64 % for the 2021 cohort to 68 % for the 2022 cohort. As the report notes: “treatment success for drug-resistant TB increased from 64 % for the 2021 cohort to 68 % for the 2022 cohort.” 

Advertisement

In the critical sphere of TB‐HIV co-infection, Zimbabwe saw a drop in the co‐infection rate to 49 %, down from 51 %. The report states: “TB/HIV co-infection rates have fallen to 49 %, down from 51 %.” 

Zooming out, the 2025 global report shows that across the world TB is falling again, although not yet at the pace required to meet targets. Globally, incidence declined by almost 2 % between 2023 and 2024, and deaths fell around 3 %. 

However, the report warns that progress is fragile. Funding shortfalls, health-system disruptions (especially during the COVID-19 era), and the ongoing challenge of drug-resistant TB threaten to erode gains. The WHO page reminds that the 2025 edition “provides a comprehensive … assessment of the TB epidemic … at global, regional and country levels.” 

Advertisement

For example, although more people are being diagnosed and treated than in previous years, not enough are being reached with preventive interventions, and many countries are still far from the targets set under the End TB Strategy.

 

Advertisement
Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage